In this regard, liver specimens from patients and animal models with NAFLD have consistently shown elevations in markers of cell proliferation, including Ki-67, E2F1, cyclin-dependent kinase 4, and gank (31–33). Here, CDK4 is linked to metabolic dysfunction-associated steatotic liver disease.